Search Medical Condition
Please enter condition
Please choose location
 

Catonsville, Maryland Clinical Trials

A listing of Catonsville, Maryland clinical trials actively recruiting patient volunteers.

RESULTS

Found (726) clinical trials

Tryptophan MRI in People With Schizophrenia and Healthy Controls

There is emerging evidence to suggest that disturbances in the kynurenine pathway may be related to the pathophysiology of schizophrenia. Several post-mortem studies have documented specific abnormalities in the kynurenine pathway, including increased levels of kynurenine and kynurenic acid (KYNA) in the prefrontal cortex of people with schizophrenia (1-4). Increased ...

Phase

0.0 miles

Learn More »

Volixibat (SHP626) in the Treatment of Adults With Nonalcoholic Steatohepatitis (NASH)

The purpose of this study is to determine if the investigational treatment volixibat (SHP626) is safe, tolerable and effective in adults with nonalcoholic steatohepatitis (NASH).

Phase

0.0 miles

Learn More »

Safety Tolerability and Efficacy Study of 12 Weeks LJN452 Treatment in NASH Patients

The purpose of the study is to assess the effects of different doses of LJN452 with respect to safety, tolerability, and on markers of liver inflammation in patients with NASH

Phase

0.0 miles

Learn More »

Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials

This registry will be used to identify patients who have etiology diagnosed or suspected to be Alzheimer's disease and positive amyloid scans, and have indicated their interest in being contacted for an Eli Lilly and Company (Lilly) Alzheimer's Disease drug research trial.

Phase N/A

0.0 miles

Learn More »

Safety Follow-up Study in Subjects With Silicone Gel-filled Breast Implants as Compared Both to Saline-filled Breast Implants and to National Norms

Ten year safety study examining rates of rare adverse events, child bearing issues, effects of mammography, MRI compliance and results, and long-term benefit of silicone-filled breast implants.

Phase N/A

0.0 miles

Learn More »

Quitting Marijuana Use: Self-Report Study of Quitting Strategies and Withdrawal Symptoms

After giving informed consent, subjects will complete three sets of questions: Marijuana Quit Questionnaire (Appendix A), Marijuana Craving Questionnaire-12-item version (Appendix B), and 8 additional questions about marijuana craving (Appendix C). These questionnaires should take about 1-2 hours to complete. A staff member will be available to assist the subject ...

Phase N/A

0.0 miles

Learn More »

Safety and Efficacy of Selonsertib in Adults With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)

The primary objective of this study is to evaluate whether selonsertib (SEL; GS-4997) can cause fibrosis regression and reduce associated complications in adults with cirrhosis due to NASH.

Phase

0.0 miles

Learn More »

Multi-Center Randomized Open-Label Study of G/P +/- RBV for NS5A + SOF Previously Treated GT1 HCV Subjects

The primary purpose of this study is to compare the efficacy and safety of glecaprevir and pibrentasvir (G/P) for 12 weeks to G/P for 16 weeks in non-cirrhotic NS5A (non-structural protein 5a)-inhibitor plus sofosbuvir ± RBV (Ribavirin) treatment-experienced adults with HCV genotype 1 (GT1) infection, and to compare the efficacy ...

Phase

0.0 miles

Learn More »

Evaluation of Clear Aligner Trays to Straighten Teeth

This is a prospective, multi-center study with a maximum duration of 24 months, to assess the safety and efficacy of 3M Clear Aligners, with the use of attachments to correct teeth malocclusions. The subject population for this study will be male and female subjects ≥ 14 years of age. Subjects ...

Phase N/A

0.0 miles

Learn More »

A Study to Evaluate Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection With APRI (a Predictor of Hepatic Fibrosis) 1 and Have Never Received HCV Treatment

A study to evaluate the efficacy and safety of glecaprevir(GLE)/pibrentasvir(PIB) in treatment-naïve participants with chronic hepatitis C virus (HCV) genotypes 1-6 infection and with an aspartate aminotransferase to platelet ratio index (APRI) of less than or equal to 1.

Phase

0.0 miles

Learn More »